Because proliferation rate and FAK are linked to cancer progression, Denoyer et al. (2005) assumed that in vivo99mTc-(V)DMSA uptake reflects tumor aggressiveness and that 99mTc-(V)DMSA uptake could provide clinicians with preoperative information not always obtainable by mammography. Here, PTK2 is linked to cancer.